LifeStance Health Group, Inc.
LFST
$6.50
-$0.06-0.92%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 13.39% | 13.86% | 16.31% | 18.50% | 20.08% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.39% | 13.86% | 16.31% | 18.50% | 20.08% |
| Cost of Revenue | 11.27% | 10.47% | 11.56% | 12.61% | 14.78% |
| Gross Profit | 18.06% | 21.60% | 27.58% | 33.20% | 33.68% |
| SG&A Expenses | 8.21% | 5.63% | 4.54% | 3.84% | 0.26% |
| Depreciation & Amortization | -28.67% | -30.67% | -25.96% | -11.79% | 1.80% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.93% | 6.34% | 6.92% | 8.37% | 9.48% |
| Operating Income | 113.93% | 100.74% | 88.90% | 76.50% | 63.12% |
| Income Before Tax | 86.54% | 86.43% | 79.71% | 72.11% | 60.78% |
| Income Tax Expenses | -131.55% | 36.73% | 82.97% | 99.16% | 124.21% |
| Earnings from Continuing Operations | 90.43% | 89.30% | 79.41% | 69.16% | 49.30% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 90.43% | 89.30% | 79.41% | 69.16% | 49.30% |
| EBIT | 113.93% | 100.74% | 88.90% | 76.50% | 63.12% |
| EBITDA | 159.78% | 3,103.58% | 307.63% | 190.62% | 135.20% |
| EPS Basic | 90.65% | 89.53% | 79.98% | 70.11% | 50.55% |
| Normalized Basic EPS | 85.89% | 80.71% | 73.20% | 62.99% | 55.65% |
| EPS Diluted | 90.86% | 88.53% | 79.23% | 68.49% | 48.96% |
| Normalized Diluted EPS | 85.81% | 80.71% | 73.20% | 62.99% | 55.65% |
| Average Basic Shares Outstanding | 2.25% | 2.35% | 2.98% | 3.59% | 3.56% |
| Average Diluted Shares Outstanding | 2.87% | 2.84% | 3.48% | 3.59% | 3.56% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |